Hovione has over 57 years of experience as a CDMO and is currently a fully integrated supplier offering from drug substance to drug product intermediate to drug product. With four FDA inspected sites in the US, China, Ireland, and Portugal, and development laboratories in Lisbon and New Jersey, the company provides branded pharmaceutical customers services for the development and compliant manufacture of innovative drugs and is able to support highly potent compounds. For generic pharmaceutical customers the company offers niche off-patent API products. In the inhalation area Hovione is the only independent company offering a complete range of services. Hovione has recently created a pharmaceutical Licensing Department identifying new indications for existing molecules. We look forward to discussing your requirements at Montreaux. Please visit visit http://www.hovione.com.
Mr Paul Thomas DunneEuropean Business Development Manager
IMI Consulting is Europe’s leading Management Consultancy and Advisory in Life Sciences having a track-record of over 27 years in servicing its clients. Because of IMI’s 150 Associate Partner network, it provides most forms of transaction and therapeutic expertise on a worldwide basis:
Strategy Development (market intelligence, development of new ways to compete, pipeline and segment analysis, Market Access and Pricing, Strategic Plans and Planning, etc.), Transaction Support (usually as implementation of the strategy, BD&L, Mergers & Acquisitions including spin-outs ) and Capital Raising.
IMI raises capital from seed to Round C, from VCs to private investors (HNW-angels).
Its 150 Associate Partner base allows specialization in most therapeutic sectors servicing Big & Specialty Pharma, Biotech, Diagnostic, MedTech, e-health and OTC/Nutritionals:
Addiction, Analgesics, Rheumatoid Arthritis, Cancer, Cardiovascular, CNS, Dermatology, Endocrinology, Gynecology, Urology, Gastrointestinal, Hematology, Life-Cycle Management, Metabolic, Molecular Diagnostics, Respiratory, Robotics, Genetic Editing, Nutritionals, OTCs, Transplantation, etc.
We cover all of Europe, USA and Asia.
Imperial Innovations is the Technology Transfer office for Imperial College London and selected NHS Trusts around London. Imperial College London is ranked in the world's top ten (QS Rankings 2018) and is the second-most innovative university in Europe (Reuters 2018).
We work closely with academic inventors to bring their research projects to market. We work with a diverse range of technologies, from diagnostics to surgical tools, therapeutics to digital healthcare solutions. We are experts in identifying, evaluating and backing technologies that meet industrial market need.
-We assess inventions, considering commercial potential, the state of the market and development requirements
-We protect intellectual property through patents and other appropriate forms of intellectual property protection
-We provide advice on establishing proof of concept, using our commercial experience to inform inventors about what businesses want to see
-We may provide development funding or support inventors in their applications for funding from other sources
-We advise on IP and commercial strategy
-We manage the licensing process (including negotiations and post-deal administration)
-Our Venture Support Unit establishes new businesses, finds mentors and management and provides access to preferred suppliers
-Above all we are flexible in our support – capable of executing novel deals and providing unique support where required.
Dr Andrew TingeyDirector of Healthcare Licensing
Indena is the leading company dedicated to the identification, development and production of high quality active principles derived from plants, for use in the pharmaceutical, health-food and personal care industries, complying with the most strict regulations. Backed up by over 90 years of botanical experience, the company has more than 120 primary patents, has published more than 700 scientific studies and co-operates with the world’s most prestigious universities and private research institutions. Headquartered in Milan, Indena has 5 production sites and 5 international branches throughout the world and manages sales in more than 70 countries.
In the supplements’ field, Indena has developed a collection of products, containing clinically validated botanical actives for a variety of health needs, ranging from the CV to the joint health field, from metabolism to the gut health sector. These ready-to-market final formulations have been designed and developed to maximize the performance of the active ingredients and to guarantee their quality and stability over time. All proposed formulations can be tailored to fulfill specific regulatory or customer requirements.
Francesca OrsiniBD&licensing manager
With 80 years of experience, Italfarmaco develops activities in the entire value chain of pharmaceutical and chemical industry, from manufacturing to commercialization and development.
Group Headquarters are located Milan, with direct presence in 26 countries across Europe, America, Asia and MENA
We are interested in licensing-in, product acquisition, M&A and licensing out
JUSTESA IMAGEN, S.A.U.
Three factors have led to large experience in licenses and collaborations:
- The consolidated presence of the Juste Group in the Spanish, Central American, and South American markets.
- Our in-house developed products.
- The growing prestige of the company since its beginning.
The Juste Group has a permanent interest in collaborating with development projects and establish license agreements and/or co-promotion for Spain, Portugal, countries from Central and South America, Middle East, and North Africa in the following fields of specialization:
- Radiology/Contrast medium